Need for Efficient Data Storage in Drug Discovery Propels Global Bioinformatics Market
News Apr 05, 2016
The global bioinformatics market is exhibiting a 20.40% CAGR from 2014 to 2020, according to a new market study recently released by Persistence Market Research. The market was calculated to be worth US$4.1 bn in 2014 and is estimated to reach US$12.5 bn by 2020, says PMR’s report, titled ‘Global Market Study on Bioinformatics - Asia to Witness Fastest Growth by 2020’.
The bioinformatics market is driven primarily by the demand for better medical data storage, retrieval, and management systems. Bioinformatics represents a combination of biology and information technology, which is helpful in several medical sectors. Drug discovery and development is a particularly promising area of application of bioinformatics. Bioinformatics methodologies help clinical researchers keep track of previous results much more efficiently and precisely than with conventional methods. This helps drug discovery and development in the long term, by eliminating manual errors in recordkeeping.
Bioinformatics also helps in personalization of medicines, a trend picking up strength in the world of healthcare in the last few years. With effective IT systems put in place by healthcare institutes, patient data can be stored and accessed in much more precise ways, helping weed out errors in the process of medicine dispensation.
On the other hand, the market for bioinformatics is restrained severely at present by the lack of trained professionals. Due to the novelty of the field, trained and competent labor is naturally hard to find, but steady acceptance of bioinformatics systems will help manufacturers overcome this roadblock. Another major restraint holding back the global bioinformatics market is the lack of interoperability between the multiple data formats and programs used by various healthcare institutions. The diversity of data formats has created fragmentation in the global market, which is expected to be solved by the R&D efforts currently underway to bring about uniformity in the bioinformatics systems manufactured by various key players.
Apart from innovation of new products and methodologies, the other key trend observed in the global bioinformatics market is that of mergers and acquisitions. Due to the relatively nascent nature of the global bioinformatics market, there are several small and medium-sized players in the market, leading to a high number of mergers and acquisitions, which will eventually result in a relatively consolidated market.
According to sector, medical biotechnology is the largest segment of the global bioinformatics market and is expected to exhibit a CAGR of 21.60% from 2014 to 2020. Other sectors in the global bioinformatics market include gene therapy, academics, agriculture biotechnology, animal biotechnology, forensic biotechnology, and environmental biotechnology.
Genomics is the largest application segment of the global bioinformatics market; it is expected to expand at a 22.50% CAGR in the same timeframe. Proteomics, metabolomics, transcriptomics, molecular phylogenomics, and chemoinformatics and drug design are other major applications of bioinformatics and are expected to exhibit steady growth in the forecast period.
View Detail Report With TOC: http://www.persistencemarketresearch.com/market-research/bioinformatics-market.asp
HIV-1 replicates in ninja-like ways. The virus slips through the membrane of vital white blood cells. Inside, HIV-1 copies its genes and scavenges parts to build a protective bubble for its copies. Now, supercomputers have helped model a key building block in the HIV-1 protective capsid, which could lead to strategies for potential therapeutic intervention in HIV-1 replication.READ MORE